By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Deciphera Pharmaceuticals 

1505 Wakarusa Drive

Lawrence  Kansas  66047  U.S.A.
Phone: 785-838-3767 Fax: 785-838-3747


SEARCH JOBS


Industry
Pharmaceutical






Company News
Deciphera’s Highly-Selective Small Molecule CSF1R Immunokinase Inhibitor, DCC-3014, Demonstrates Potent Macrophage Checkpoint Inhibition As A Single Agent And In Combination With An Anti-PD1 Inhibitor 4/20/2016 11:38:08 AM
Deciphera Announces Study Results For Altiratinib Demonstrating Inhibition Of Tumor Growth And Invasiveness In Glioblastoma 3/21/2016 8:34:56 AM
Deciphera To Present Data On Its Highly-Selective Small Molecule CSF1R Immunokinase Inhibitor, DCC-3014, At AACR Annual Meeting 2016 3/17/2016 10:39:19 AM
Deciphera To Present At American Chemical Society Annual Meeting 3/9/2016 11:04:56 AM
Deciphera To Present At Future Leaders In The Biotech Industry Conference 2/29/2016 11:34:16 AM
Deciphera Increases Size Of Series B Financing To Over $90 Million With Addition Of SV Life Sciences 1/5/2016 10:26:14 AM
Deciphera To Present At Oppenheimer Annual Healthcare Conference 12/1/2015 10:37:30 AM
Deciphera To Present At Piper Jaffray Healthcare Conference 11/24/2015 9:38:22 AM
Akari, Deciphera Both Nab $75 Million in Financing 9/21/2015 6:09:44 AM
Deciphera Pharmaceuticals Announces Study Results For Altiratinib Demonstrating Inhibition Of Three Major Cancer-Promoting Pathways To Durably Block Tumor Growth And Invasion 8/18/2015 11:07:29 AM
123
//-->